SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World’s Population
Fifty ~20–amino acid (aa)–long peptides were selected from functionally relevant SARS-CoV-2 S, M, and E proteins for trial B-21 and another 53 common ones, plus some new ones derived from the virus’ main genetic variants for complementary trial C-21. Peptide selection was based on tremendous SARS-Co...
- Autores:
-
Patarroyo, Manuel-Alfonso
Patarroyo, Manuel-Elkin
Pabón, Laura
Alba, Martha patricia
Bermúdez, Adriana
Rugeles, María Teresa
Díaz-Arevalo, Diana
Zapata, María Isabel
Reyes, César
Suárez, Carlos F.
Agudelo, William
Zapata, Wildeman
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2022
- Institución:
- Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
- Repositorio:
- Repositorio Institucional UDCA
- Idioma:
- eng
- OAI Identifier:
- oai:repository.udca.edu.co:11158/4811
- Acceso en línea:
- https://repository.udca.edu.co/handle/11158/4811
- Palabra clave:
- Péptidos sintéticos
Coronavirus del síndrome respiratorio agudo grave 2
Variantes
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.es